Round Hill Asset Management Acquires Shares of 38,173 Kenvue Inc. $KVUE

Round Hill Asset Management bought a new stake in Kenvue Inc. (NYSE:KVUE) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,173 shares of the company’s stock, valued at approximately $620,000.

A number of other institutional investors also recently bought and sold shares of KVUE. AlphaCore Capital LLC increased its holdings in shares of Kenvue by 9.9% in the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares during the last quarter. Empirical Finance LLC increased its stake in Kenvue by 1.8% in the second quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock valued at $593,000 after purchasing an additional 491 shares during the last quarter. J.W. Cole Advisors Inc. increased its stake in Kenvue by 3.8% in the second quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock valued at $324,000 after purchasing an additional 574 shares during the last quarter. Spire Wealth Management raised its holdings in Kenvue by 13.5% during the second quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock worth $102,000 after purchasing an additional 580 shares in the last quarter. Finally, Versor Investments LP lifted its position in shares of Kenvue by 2.8% during the 3rd quarter. Versor Investments LP now owns 26,016 shares of the company’s stock worth $422,000 after buying an additional 716 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Kenvue Stock Performance

NYSE:KVUE opened at $19.11 on Monday. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66. The firm’s fifty day simple moving average is $17.72 and its 200-day simple moving average is $17.50. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The stock has a market cap of $36.62 billion, a PE ratio of 24.81, a price-to-earnings-growth ratio of 4.38 and a beta of 0.59.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period last year, the firm earned $0.26 EPS. Analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were given a $0.2075 dividend. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.3%. Kenvue’s dividend payout ratio (DPR) is currently 107.79%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on KVUE shares. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price objective for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Barclays raised their price objective on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Finally, Edward Jones lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $19.50.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The shares were acquired at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.68% of the stock is owned by company insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.